Copyright Reports & Markets. All rights reserved.

Global Catheter-Based Renal Denervation System Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Catheter-Based Renal Denervation System Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Radiofrequency Ablation
    • 1.3.3 Ultrasound Ablation
    • 1.3.4 Others
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Catheter-Based Renal Denervation System Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 High Blood Pressure Treatment
    • 1.4.3 Others
  • 1.5 Global Catheter-Based Renal Denervation System Market Size & Forecast
    • 1.5.1 Global Catheter-Based Renal Denervation System Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Catheter-Based Renal Denervation System Sales Quantity (2021-2032)
    • 1.5.3 Global Catheter-Based Renal Denervation System Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Medtronic
    • 2.1.1 Medtronic Details
    • 2.1.2 Medtronic Major Business
    • 2.1.3 Medtronic Catheter-Based Renal Denervation System Product and Services
    • 2.1.4 Medtronic Catheter-Based Renal Denervation System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Medtronic Recent Developments/Updates
  • 2.2 Recor Medical
    • 2.2.1 Recor Medical Details
    • 2.2.2 Recor Medical Major Business
    • 2.2.3 Recor Medical Catheter-Based Renal Denervation System Product and Services
    • 2.2.4 Recor Medical Catheter-Based Renal Denervation System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Recor Medical Recent Developments/Updates
  • 2.3 Boston Scientific
    • 2.3.1 Boston Scientific Details
    • 2.3.2 Boston Scientific Major Business
    • 2.3.3 Boston Scientific Catheter-Based Renal Denervation System Product and Services
    • 2.3.4 Boston Scientific Catheter-Based Renal Denervation System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Boston Scientific Recent Developments/Updates
  • 2.4 Cardiosonic
    • 2.4.1 Cardiosonic Details
    • 2.4.2 Cardiosonic Major Business
    • 2.4.3 Cardiosonic Catheter-Based Renal Denervation System Product and Services
    • 2.4.4 Cardiosonic Catheter-Based Renal Denervation System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Cardiosonic Recent Developments/Updates
  • 2.5 Shanghai Bioheart
    • 2.5.1 Shanghai Bioheart Details
    • 2.5.2 Shanghai Bioheart Major Business
    • 2.5.3 Shanghai Bioheart Catheter-Based Renal Denervation System Product and Services
    • 2.5.4 Shanghai Bioheart Catheter-Based Renal Denervation System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Shanghai Bioheart Recent Developments/Updates
  • 2.6 Shanghai Golden Leaf
    • 2.6.1 Shanghai Golden Leaf Details
    • 2.6.2 Shanghai Golden Leaf Major Business
    • 2.6.3 Shanghai Golden Leaf Catheter-Based Renal Denervation System Product and Services
    • 2.6.4 Shanghai Golden Leaf Catheter-Based Renal Denervation System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Shanghai Golden Leaf Recent Developments/Updates
  • 2.7 Suzhou SyMap
    • 2.7.1 Suzhou SyMap Details
    • 2.7.2 Suzhou SyMap Major Business
    • 2.7.3 Suzhou SyMap Catheter-Based Renal Denervation System Product and Services
    • 2.7.4 Suzhou SyMap Catheter-Based Renal Denervation System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Suzhou SyMap Recent Developments/Updates
  • 2.8 MicroPort
    • 2.8.1 MicroPort Details
    • 2.8.2 MicroPort Major Business
    • 2.8.3 MicroPort Catheter-Based Renal Denervation System Product and Services
    • 2.8.4 MicroPort Catheter-Based Renal Denervation System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 MicroPort Recent Developments/Updates
  • 2.9 Cryofocus Medtech
    • 2.9.1 Cryofocus Medtech Details
    • 2.9.2 Cryofocus Medtech Major Business
    • 2.9.3 Cryofocus Medtech Catheter-Based Renal Denervation System Product and Services
    • 2.9.4 Cryofocus Medtech Catheter-Based Renal Denervation System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Cryofocus Medtech Recent Developments/Updates
  • 2.10 Shanghai Hantong
    • 2.10.1 Shanghai Hantong Details
    • 2.10.2 Shanghai Hantong Major Business
    • 2.10.3 Shanghai Hantong Catheter-Based Renal Denervation System Product and Services
    • 2.10.4 Shanghai Hantong Catheter-Based Renal Denervation System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Shanghai Hantong Recent Developments/Updates

3 Competitive Environment: Catheter-Based Renal Denervation System by Manufacturer

  • 3.1 Global Catheter-Based Renal Denervation System Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Catheter-Based Renal Denervation System Revenue by Manufacturer (2021-2026)
  • 3.3 Global Catheter-Based Renal Denervation System Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Catheter-Based Renal Denervation System by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Catheter-Based Renal Denervation System Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Catheter-Based Renal Denervation System Manufacturer Market Share in 2025
  • 3.5 Catheter-Based Renal Denervation System Market: Overall Company Footprint Analysis
    • 3.5.1 Catheter-Based Renal Denervation System Market: Region Footprint
    • 3.5.2 Catheter-Based Renal Denervation System Market: Company Product Type Footprint
    • 3.5.3 Catheter-Based Renal Denervation System Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Catheter-Based Renal Denervation System Market Size by Region
    • 4.1.1 Global Catheter-Based Renal Denervation System Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Catheter-Based Renal Denervation System Consumption Value by Region (2021-2032)
    • 4.1.3 Global Catheter-Based Renal Denervation System Average Price by Region (2021-2032)
  • 4.2 North America Catheter-Based Renal Denervation System Consumption Value (2021-2032)
  • 4.3 Europe Catheter-Based Renal Denervation System Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Catheter-Based Renal Denervation System Consumption Value (2021-2032)
  • 4.5 South America Catheter-Based Renal Denervation System Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Catheter-Based Renal Denervation System Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Catheter-Based Renal Denervation System Sales Quantity by Type (2021-2032)
  • 5.2 Global Catheter-Based Renal Denervation System Consumption Value by Type (2021-2032)
  • 5.3 Global Catheter-Based Renal Denervation System Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Catheter-Based Renal Denervation System Sales Quantity by Application (2021-2032)
  • 6.2 Global Catheter-Based Renal Denervation System Consumption Value by Application (2021-2032)
  • 6.3 Global Catheter-Based Renal Denervation System Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Catheter-Based Renal Denervation System Sales Quantity by Type (2021-2032)
  • 7.2 North America Catheter-Based Renal Denervation System Sales Quantity by Application (2021-2032)
  • 7.3 North America Catheter-Based Renal Denervation System Market Size by Country
    • 7.3.1 North America Catheter-Based Renal Denervation System Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Catheter-Based Renal Denervation System Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Catheter-Based Renal Denervation System Sales Quantity by Type (2021-2032)
  • 8.2 Europe Catheter-Based Renal Denervation System Sales Quantity by Application (2021-2032)
  • 8.3 Europe Catheter-Based Renal Denervation System Market Size by Country
    • 8.3.1 Europe Catheter-Based Renal Denervation System Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Catheter-Based Renal Denervation System Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Catheter-Based Renal Denervation System Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Catheter-Based Renal Denervation System Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Catheter-Based Renal Denervation System Market Size by Region
    • 9.3.1 Asia-Pacific Catheter-Based Renal Denervation System Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Catheter-Based Renal Denervation System Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Catheter-Based Renal Denervation System Sales Quantity by Type (2021-2032)
  • 10.2 South America Catheter-Based Renal Denervation System Sales Quantity by Application (2021-2032)
  • 10.3 South America Catheter-Based Renal Denervation System Market Size by Country
    • 10.3.1 South America Catheter-Based Renal Denervation System Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Catheter-Based Renal Denervation System Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Catheter-Based Renal Denervation System Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Catheter-Based Renal Denervation System Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Catheter-Based Renal Denervation System Market Size by Country
    • 11.3.1 Middle East & Africa Catheter-Based Renal Denervation System Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Catheter-Based Renal Denervation System Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Catheter-Based Renal Denervation System Market Drivers
  • 12.2 Catheter-Based Renal Denervation System Market Restraints
  • 12.3 Catheter-Based Renal Denervation System Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Catheter-Based Renal Denervation System and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Catheter-Based Renal Denervation System
  • 13.3 Catheter-Based Renal Denervation System Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Catheter-Based Renal Denervation System Typical Distributors
  • 14.3 Catheter-Based Renal Denervation System Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Catheter-Based Renal Denervation System market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
    Renal Denervation (RDN) is a percutaneous interventional treatment method. It mainly uses energy such as radio frequency and ultrasound to eliminate the afferent and efferent nerves in the renal artery, blocking the signal conduction between the brain and sympathetic nerves to a certain extent, thereby reducing the risk of high blood pressure. The sympathetic nerve excitability of patients with high blood pressure can achieve long-term and stable blood pressure lowering effects with one minimally invasive surgery.
    Currently, the typical models of Renal Denervation (RDN) System include Recor Medical’s Paradise and Medtronic’s Simplicity Spyral, etc.
    This report is a detailed and comprehensive analysis for global Catheter-Based Renal Denervation System market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Catheter-Based Renal Denervation System market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Catheter-Based Renal Denervation System market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Catheter-Based Renal Denervation System market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Catheter-Based Renal Denervation System market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Catheter-Based Renal Denervation System
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Catheter-Based Renal Denervation System market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Medtronic, Recor Medical, Boston Scientific, Cardiosonic, Shanghai Bioheart, Shanghai Golden Leaf, Suzhou SyMap, MicroPort, Cryofocus Medtech, Shanghai Hantong, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Catheter-Based Renal Denervation System market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Radiofrequency Ablation
    Ultrasound Ablation
    Others
    Market segment by Application
    High Blood Pressure Treatment
    Others
    Major players covered
    Medtronic
    Recor Medical
    Boston Scientific
    Cardiosonic
    Shanghai Bioheart
    Shanghai Golden Leaf
    Suzhou SyMap
    MicroPort
    Cryofocus Medtech
    Shanghai Hantong
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Catheter-Based Renal Denervation System product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Catheter-Based Renal Denervation System, with price, sales quantity, revenue, and global market share of Catheter-Based Renal Denervation System from 2021 to 2026.
    Chapter 3, the Catheter-Based Renal Denervation System competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Catheter-Based Renal Denervation System breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Catheter-Based Renal Denervation System market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Catheter-Based Renal Denervation System.
    Chapter 14 and 15, to describe Catheter-Based Renal Denervation System sales channel, distributors, customers, research findings and conclusion.

    Buy now